首页 › 基金 › Kalehua Capital Management LLC › ATOS

Kalehua Capital Management LLC 对 ATOS 的持仓历史

Attovia Therapeutics Inc · 医疗保健

Kalehua Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 ATOS(Attovia Therapeutics Inc)200,000 股,市值约 US$3.4M,约占其申报组合的 2.59%,在其申报持仓中市值排名第 13 位。 Kalehua Capital Management LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)200.00K 股
申报持仓市值$3.43M
组合权重2.59%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Kalehua Capital Management LLC 对 ATOS 的持仓演变

Kalehua Capital Management LLC 于 Q3 2026 首次披露 ATOS 持仓:200,000 股(约 US$3.4M)。

逐季持仓明细

季度股数金额变化
Q3 2026 200.00K $3.43M 新进

关于 ATOS 与 13F 数据

ATOS(Attovia Therapeutics Inc)属于医疗保健行业。我们追踪的基金中还有 24 只申报持有 ATOS,申报仓位最大的包括:Sanofi (US$18.6M), Vivo Capital, LLC (US$5.1M), Jones Hill Capital LP (US$3.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ATOS 的基金

查看 ATOS 的全部基金持有人 →

常见问题

How long has Kalehua Capital Management LLC held ATOS?

Kalehua Capital Management LLC has disclosed ATOS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Kalehua Capital Management LLC's current position in ATOS?

As of Q3 2026, Kalehua Capital Management LLC holds 200.00K shares of ATOS (Attovia Therapeutics Inc), valued at $3.43M, representing 2.59% of its reported portfolio and ranking #13.

Has Kalehua Capital Management LLC been buying or selling ATOS?

In the latest 13F filing (Q3 2026), Kalehua Capital Management LLC newly opened its position in ATOS.

Which other funds hold ATOS?

Other major institutional holders of ATOS include Sanofi, Vivo Capital, LLC, Jones Hill Capital LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.